COMMUNIQUÉS West-GlobeNewswire

Smart for Life to be Featured in Whole Foods Magazine Highlighting Product Offerings, Strategic Acquisitions and Expansion Initiatives
31/05/2024
Company Representatives to Explore Strategies for Emerging Growth Companies in the Health & Wellness Sector MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL), a prominent leader in the [...]
Alberta Cancer Foundation announces new Breakthrough Fund recipient, driving commercial success of cancer research breakthroughs
31/05/2024
Local startup Oncobiotix to receive $100,000 to advance cancer and microbiome research CALGARY, Alberta, May 31, 2024 (GLOBE NEWSWIRE) -- The Alberta Cancer Foundation is pleased to announce the latest recipient of the [...]
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine
31/05/2024
If approved, IXCHIQ ® will become the first vaccine available in the EU against the chikungunya virus (CHIKV) Decision on EU marketing authorization expected in the third quarter of 2024 Saint Herblain (France), May 31 [...]
Valneva reçoit un avis positif du CHMP pour une autorisation de mise sur le marché en Europe de son vaccin contre le chikungunya
31/05/2024
En cas d’approbation, IXCHIQ ® deviendra le premier vaccin disponible dans l'UE contre le virus du chikungunya (CHIKV) Une décision sur la demande d’autorisation de mise sur le marché européen est attendue au troisième [...]
OPKO Health to Participate in the Jefferies Global Healthcare Conference
31/05/2024
MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott [...]
Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine
31/05/2024
COPENHAGEN, Denmark, May 31, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval [...]
AB Science is providing a summary of the live webcast held on May 30, 2024, giving an update on the application for conditional marketing authorization of masitinib in ALS
31/05/2024
PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON MAY 30, 2024, PROVIDING AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, May 31, [...]
AB Science fournit un résumé de la conférence virtuelle qui s'est tenue le 30 mai 2024, faisant le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA
31/05/2024
COMMUNIQUE DE PRESSE RESUME DE LA CONFERENCE VIRTUELLE DU 30 MAI 2024 FAISANT LE POINT SUR LA DEMANDE D'AUTORISATION CONDITIONNELLE DE MISE SUR LE MARCHE DU MASITINIB DANS LE TRAITEMENT DE LA SCLEROSE LATERALE [...]
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency
31/05/2024
Press release – No. 6 / 2024 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency Copenhagen, Denmark, May 31, 2024 – Zealand [...]
JDRF Walk to Cure Diabetes
31/05/2024
Throughout June close to 50 communities will be gathering across Canada to raise funds for type 1 diabetes research TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- The JDRF Walk to Cure Diabetes is the largest fundraising [...]
Marche pour la guérison du diabète FRDJ
31/05/2024
Tout au long du mois de juin, près de 50 communautés se réuniront dans tout le Canada pour amasser des fonds en faveur de la recherche sur le diabète de type 1 TORONTO, 31 mai 2024 (GLOBE NEWSWIRE) -- La Marche pour la [...]
DBV Technologies Announces Plan to Implement ADS Ratio Change
31/05/2024
Châtillon, France, May 31, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), a clinical-stage [...]
DBV Technologies annonce son intention de modifier le ratio d'ADS
31/05/2024
Châtillon, France, le 31 mai 2024 DBV Technologies annonce son intention de modifier le ratio d'ADS DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), une société [...]
Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response with MDNA11 in the Dose Escalation Portion of Phase 1/2 ABILITY-1 Study at the 10th Annual Oncology Innovation Forum
31/05/2024
MDNA11 demonstrates durable response in pancreatic cancer patient with 100% regression of target and non-target lesions for over 104 weeks and continues to show remission 4 months after stopping treatment Melanoma [...]
Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
31/05/2024
Established Medium Dose as Safe and Tolerable Dose in Current OCU410 Clinical Trial DSMB Recommends Continuing with High-Dose Cohort Dosing with Concurrent Phase 2 Dosing MALVERN, Pa., May 31, 2024 (GLOBE NEWSWIRE) -- [...]
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
31/05/2024
OCALA, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional [...]
Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
31/05/2024
Sharps CEO issues letter to shareholders with details about the InjectEZ acquisition, establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. Signed Syringe Sales Agreement will secure product [...]
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
31/05/2024
Year marked by operational and clinical execution advancing the development of a potential breakthrough technology for the nervous system Continued progress in first study ever to evaluate radiofrequency (RF) ablation [...]
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the Human Healthspan
31/05/2024
Backed by decades of longevity science, platform measures “biological noise” to determine age and fitness of key body systems aimed at cell regeneration and age reversal SAN FRANCISCO, May 31, 2024 (GLOBE NEWSWIRE) -- [...]

Pages